27 February 2008
The effect of 30 Hz vs. 50 Hz passive vibration and duration of vibration on skin blood flow in the armColleen Maloney-HindsABCDEF, Jerrold Scott PetrofskyABCDEF, Grenith ZimmermanACDE
Med Sci Monit 2008; 14(3): CR112-116 :: ID: 836575
Recently, researchers have demonstrated that Whole Body Vibration (WBV) results in significant increases in skin blood flow (SBF). No study has determined if a specific frequency or a specific duration is better at optimizing SBF.
Material and Method
Two studies were conducted to determine, 1) if there is a difference in SBF due to passive vibration of the forearm at 30 Hz vs. 50 Hz, 2) if one frequency is superior, and 3) if there is an optimal duration. In the first study, 18 subjects (mean age 20.3+/-2.9 years) were randomly placed into a 30 Hz or 50 Hz vibration group, and in the second, seven subjects (mean age 23.3+/-3.8 years) participated in both 30 and 50 Hz vibration. Each subject's arm was passively vibrated for 10 minutes. SBF was examined during vibration and for 15 minutes of recovery.
Both frequencies produced significant increases in SBF (p<0.05) within the first four minutes of vibration. Peak SBFs were obtained by the fifth minute. SBF remained high for minutes 4 through 10 of vibration in the second study. In the first study, SBF remained high for minutes 4 through 9. During recovery, 30 Hz vibration produced SBFs below baseline values while 50 Hz SBFs remained above baseline. Statistically one frequency was not superior to the other.
Five minutes of 30 Hz or 50 Hz vibration produced significant increases in SBF. Clinically, 50 Hz has additional benefits because SBF increased more rapidly and did not result in vasoconstriction during the recovery period. Future studies should be done to determine if these increases in SBF could be of benefit to populations with low circulation such as those with diabetes.
Keywords: Skin - blood supply, Regional Blood Flow, Vibration, Arm - blood supply, Adolescent
01 December 2022 : EditorialEditorial: The World Health Organization (WHO) Fungal Priority Pathogens List in Response to Emerging Fungal Pathogens During the COVID-19 Pandemic
Med Sci Monit 2022; 28:e939088
29 November 2022 : Clinical ResearchRetrospective Study to Identify Risk Factors for Severe Disease and Mortality Using the Modified Early Warn...
Med Sci Monit In Press; DOI: 10.12659/MSM.938647
24 November 2022 : Clinical ResearchA Prospective Questionnaire-Based Study to Evaluate Factors Affecting the Decision to Receive COVID-19 Vacc...
Med Sci Monit In Press; DOI: 10.12659/MSM.938665
01 December 2022 : EditorialEditorial: The World Health Organization (WHO) Fungal Priority Pathogens List in Response to Emerging Funga...
Med Sci Monit 2022; 28:e939088
05 Dec 2022 : Database AnalysisImpact of the De Ritis Ratio on the Prognosis of Patients with Stable Coronary Artery Disease Undergoing Pe...
Med Sci Monit In Press; DOI: 10.12659/MSM.937737
02 Dec 2022 : Clinical ResearchValue of Early Laparoscopic Exploration for Primary Infertile Patients with Patent Fallopian Tubes Complica...
Med Sci Monit In Press; DOI: 10.12659/MSM.938637
02 Dec 2022 : Clinical ResearchSingle-Center Study in Lithuania to Evaluate the Role of Transthoracic Impedance Cardiography in the Diagno...
Med Sci Monit In Press; DOI: 10.12659/MSM.938389
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
01 Nov 2020 : Review articleLong-Term Respiratory and Neurological Sequelae of COVID-19
Med Sci Monit 2020; 26:e928996